Thank you so much. My apologies, as this email request was originally sent back in 2022, and we did end up adding NUTM1 Renal Cell Carcinoma.
Thank you for following up on this. I appreciate your time and assistance.
--
You received this message because you are subscribed to a topic in the Google Groups "OncoTree Users" group.
To unsubscribe from this topic, visit https://groups.google.com/d/topic/oncotree-users/85e8rJWukrQ/unsubscribe.
To unsubscribe from this group and all its topics, send an email to oncotree-user...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/oncotree-users/27ed8903-fb0a-4db5-a7c0-20b7c744be94n%40googlegroups.com.